Similarly, SMD‐based improvements in FBG and HOMA‐IR for better glycemic control and insulin sensitivity are associated with lower microvascular risk and, in T2DM, incremental macrovascular benefit when sustained [48, 50]. Here, INS is linked to type 2 diabetes mellitus.